Drugs
WASHINGTON, DC: Clinical Study Initiated With Novel Treatment for Sanfilippo Syndrome Using NAV rAAVrh.10 Vector ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwire) -- 02/28/12 -- (ASX: ACL), today announced that Peter Smith, Alchemia's Chief Executive Officer, is scheduled to present at the 32nd Annual Cowen Health Care ...
LONDON: LONDON -- (Marketwire) -- 02/28/12 -- Laboratories performing molecular or genetic diagnostic testing play a vital strategic role in the success of personalized medicine (PM), but are often the " ...
BUENA PARK, CA: SOHM Expects Revenue to More Than Double by End of 2012 ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/24/12 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to ...
WOODBRIDGE, ONTARIO: WOODBRIDGE, ONTARIO -- (Marketwire) -- 02/22/12 -- Pivotal Therapeutics Inc. (CNSX: PVO), a specialty pharmaceutical company with a focus on the treatment of cardiovascular disease and overall healt ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 02/22/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Gary Titus, Chief Financial Officer, will present a corporate overview and business u ...
RESEARCH TRIANGLE PARK, NC: RESEARCH TRIANGLE PARK, NC -- (Marketwire) -- 02/16/12 -- Morria Biopharmaceuticals Plc has selected SCYNEXIS, Inc. as their chemical development and production partner for the first-in-class non-st ...
FLEMINGTON, NJ: Beardsworth's Site Ambassador Program Focuses on Stronger Clinical Site Relationships ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/14/12 -- (TSX VENTURE: SBM)(PINKSHEETS: SRBCF)(FRANKFURT: ZSB), a biotechnology company specializing in , announced today it has appointed organic c ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/14/12 -- (TSX VENTURE: SBM)(PINKSHEETS: SRBCF)(FRANKFURT: ZSB) (the "Company"), a biotechnology company, announced today it has completed ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwire) -- 02/13/12 -- Pharmacists supporting the "I Care About My Pharmacist" campaign are deeply concerned about today's announcement from the Minister of ...
BAINBRIDGE ISLAND, WA: BAINBRIDGE ISLAND, WA -- (Marketwire) -- 02/13/12 -- A leading protein science solutions company today announced strategic changes including new leadership and a new company name. Emerald BioSystems, ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/09/12 -- Theravance, Inc. (NASDAQ: THRX) reported today its financial results for the fourth quarter and full year ended December 31, 2011. Revenue for ...
SOUTH SAN FRANCISCO, CA: Patients Report High Satisfaction, Decreased Opioid Dependence Problems and Significant Overall Improvement With Probuphine; NDA Expected to Be Filed in 3Q 2012 ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 02/08/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the following ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwire) -- 02/07/12 -- NuPathe Inc. (NASDAQ: PATH), an emerging biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseas ...
BOSTON, MA and SAN RAMON, CA: Partnership Helps Nextrials Expand Into Latin America and Provides ESTERN's Sponsors With Better Investigator Site Data and Cost Control ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 02/06/12 -- Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced the completion of an underwritten public offering of 9,775,000 shares of its common stock, includi ...
PARSIPPANY, NJ: Conference Call to Be Held at 8:30 a.m. Eastern Time ...
